KB Financial Partners’s Idexx Laboratories IDXX Stock Holding History

KB Financial Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$76K	Buy	174 +25	+17%	+$12.5K	0.02%	219
2023 Q2	$75K	Buy	149 +23	+18%	+$11K	0.02%	231
2023 Q1	$63K	Sell	126 -103	-45%	-$49.3K	0.02%	237
2022 Q4	$93K	Sell	229 -12	-5%	-$4.66K	0.03%	217
2022 Q3	$79K	Sell	241 -47	-16%	-$17.3K	0.03%	216
2022 Q2	$101K	Buy	288 +59	+26%	+$24.1K	0.03%	209
2022 Q1	$125K	Buy	229 +120	+110%	+$63.1K	0.03%	210
2021 Q4	$72K	Buy	+109	New	+$68.4K	0.02%	252
2021 Q3	–	Sell	-112	Closed	-$71K	–	348
2021 Q2	$71K	Sell	112 -13	-10%	-$7.18K	0.03%	235
2021 Q1	$61K	Buy	+125	New	+$62.6K	0.03%	248

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

KB Financial Partners's IDXX Position: Q3 2023 in Review

KB Financial Partners increased its Idexx Laboratories (IDXX) stake by 17% in Q3 2023, buying an estimated $12.5K and bringing the position to 174 shares worth $76K. The position accounts for 0.02% of the portfolio, ranked #219.

KB Financial Partners first reported a position in IDXX in Q1 2021 and has held it in 10 quarters since. The position peaked at $125K in Q1 2022. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

KB Financial Partners held 174 shares of Idexx Laboratories worth $76K as of Q3 2023.
KB Financial Partners bought 25 Idexx Laboratories shares in Q3 2023, an estimated $12.5K.
Idexx Laboratories made up 0.02% of KB Financial Partners's portfolio in Q3 2023, its #219 holding.
KB Financial Partners first reported a position in Idexx Laboratories in Q1 2021 and has held it in 10 quarters since.
KB Financial Partners's Idexx Laboratories position peaked at $125K in Q1 2022.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.